-
Update April 20 - April 26, 2020, dr. Peter J. Lansberg MD,
PhD
Weekly COVID-19 Literature Update will keep you up-to-date
with all recent PubMed publications
categorized by relevant topics
COVID-19 publications - Week 17 2020556
Publications
PubMed based Covid-19 weekly literature updateFor those
interested in receiving weekly updates
click hereFor questions and requests for topics to add send an
e-mail
[email protected]
Reliable on-line resources for Covid 19
WHO Daily dashbord Country
Guidance Travel restriction CDCCovid
CounterAHAESCWikipediaEMEAEvidence EPPIGenomic epidemiology CEBM
- OxfordNice Guidelines Covid decisions Corona Resource
Center Harvard Am College of Surgeons guidelines PPE Burn Rate
Calculator (CDC)Medscape Covid GuidelinesCOVID-19 resources
(McMasters)
BMJCambridge Univeristy PressCochraneElsevierJAMAThe LancetNew
England Journal of MedicineOxford Universtiy PressPLOSSpringer
NatureWileySSRN (Preprints) COVID reference (Steinhauser
Verlag)Cell Papers
http://eepurl.com/gXith5https://unwfp.maps.arcgis.com/apps/opsdashboard/index.html#/db5b5df309ac4f10bfd36145a6f8880ehttps://unwfp.maps.arcgis.com/apps/opsdashboard/index.html#/db5b5df309ac4f10bfd36145a6f8880ehttps://www.cdc.gov/coronavirus/2019-ncov/index.htmlhttps://www.worldometers.info/coronavirus/https://www.heart.org/en/about-us/coronavirus-covid-19-resourceshttps://www.escardio.org/Education/COVID-19-and-Cardiologyhttps://www.wikiwand.com/nl/COVID-19https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19https://nextstrain.org/ncovhttps://www.cebm.net/covid-19/https://www.criticalcarenice.org.uk/clinical-guidelineshttps://www.health.harvard.edu/diseases-and-conditions/coronavirus-resource-center?utm_content=buffer5d9d6&utm_medium=social&utm_source=twitter&utm_campaign=bufferhttps://www.facs.org/covid-19/clinical-guidancehttps://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/burn-calculator.htmlhttps://www.medscape.com/index/list_13405_0https://www.mcmasterforum.org/find-evidence/guide-to-covid-19-evidence-sourceshttps://www.nejm.org/coronavirushttps://blogs.plos.org/plos/2020/01/novel-coronavirus-2019-ncov-outbreak/https://www.springernature.com/gp/researchers/campaigns/coronavirushttps://www.ssrn.com/index.cfm/en/coronavirus/https://covidreference.com/https://www.cell.com/2019-nCOV
-
COVID-19 TELEMEDIZIN (BMJ)Korean CDC Covid-19
guidelinesOxygenation Ventilation toolkit COVID-19 Projections
trackerAAN - Neurology resources
GuidelinesNice Guidelines Covid decisions Korean CDC Covid-19
guidelinesIDSA COVID-19 GuidelinesAirway Management Clinical
Practice Guidelines (SIAARTI/EAMS, 2020) ESICM Ventilation
Guidelines Performing Procedures on Patients With Known or
Suspected COVID-19 (ASA, 2020)OSHA Guidance on Preparing the
Workplace for COVID-19 (2020) Policy for Sterilizers, Disinfectant
Devices, and Air Purifiers (FDA, 2020)Breast Cancer Patient Triage
Guidelines (CPBCC, 2020) clinical guidance for adult Belgian
patients, suspected or confirmed COVID-19National Covid-19 Testing
Action Plan (Rockefeller Foundation) ASE issues Echo-cardiography
guidance
Trials & RegistriesCAPACITY European registry COVID 19
patients WHO launches global megatrial FDA launches Convalescent
plasma trialLets Beat Covid-19 Survey to help plan hospital
servicesCOVID IBD registry Google mobility reports per country
COVID 19World's largest trial of potential coronavirus treatments
rolled out across the UK Pregnancy Registry (US)ICNARC report on
COVID-19 in critical care - NHS April 24
Mainstream MediaRichard Lehman's COVID 19 review April 6
(BMJ)
Who will remain immune to COVID-19? (NYT)AstraZeneca’s Calquence
Shows Early Promise For COVID-19 Patients (Forbes)Small Chloroquine
Study Halted Over Risk of Fatal Heart Complications (NYT)
New Therapies to Treat COVID-19 (Consumer Reports)Healthcare
workers 'should be screened for COVID-19 every week'
Is the Virus on My Clothes? My Shoes? My Hair? My
Newspaper? (NYT)Asthma Is Absent Among Top COVID-19 Risk Factors,
Early Data Shows (NYT)
Does Widespread Disinfecting Kill the Coronavirus? It’s Under
Debate (NYT) Coronavirus: Which Mask Should You Wear (NYT)?
20 percent of coronavirus ICU patients in NYC need dialysis
(Politico) Obesity Linked to Severe COVID-19 Disease, Especially
for Younger Patients (NYT)
How good is the "6 feet" science of social distancing (NYT)How
does coronavirus kill? (Science)
Basic Science
https://www.bmj.com/content/368/bmj.m1182/relatedhttps://covidtranslate.org/https://cpr.heart.org/en/resources/coronavirus-covid19-resources-for-cpr-training/oxygenation-and-ventilation-of-covid-19-patientshttp://covid%20projections%20tracherd/https://www.aan.com/tools-and-resources/covid-19-neurology-resource-center/https://www.criticalcarenice.org.uk/clinical-guidelineshttps://covidtranslate.org/https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://onlinelibrary.wiley.com/doi/full/10.1111/anae.15049https://www.esicm.org/wp-content/uploads/2020/03/SSC-COVID19-GUIDELINES.pdfhttps://www.asahq.org/about-asa/governance-and-committees/asa-committees/committee-on-occupational-health/coronavirushttps://www.osha.gov/Publications/OSHA3990.pdfhttps://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-ventilators-and-accessories-and-other-respiratory-devices-during-coronavirushttps://www.facs.org/covid-19/clinical-guidance/elective-case/breast-cancerhttps://epidemio.wiv-isp.be/ID/Documents/Covid19/COVID-19_InterimGuidelines_Treatment_ENG.pdfhttps://t.co/HtbvKckQUw?amp=1http://www.onlinejacc.org/content/early/2020/04/06/j.jacc.2020.04.002https://capacity-covid.eu/https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatmentshttps://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/investigational-covid-19-convalescent-plasma-emergency-indshttps://letsbeatcovid.net/https://covidibd.org/https://www.google.com/covid19/mobility/https://www.gov.uk/government/news/worlds-largest-trial-of-potential-coronavirus-treatments-rolled-out-across-the-ukhttps://www.gov.uk/government/news/worlds-largest-trial-of-potential-coronavirus-treatments-rolled-out-across-the-ukhttps://www.obgproject.com/2020/03/26/u-s-covid-19-pregnancy-registry-now-open/https://www.icnarc.org/Our-Audit/Audits/Cmp/Reportshttps://blogs.bmj.com/bmj/2020/04/06/richard-lehmans-covid-19-reviews-6-april-2020/https://www.forbes.com/sites/nathanvardi/2020/04/13/exclusive-astrazenecas-calquence-shows-early-promise-for-covid-19-patients/#49b63d6e4677https://www.nytimes.com/2020/04/12/health/chloroquine-coronavirus-trump.html?algo=identity&fellback=false&imp_id=211761614&imp_id=494670681&action=click&module=Science%20%20Technology&pgtype=Homepagehttps://www.consumerreports.org/medical-treatments-procedures/new-therapies-to-treat-covid-19/?linkId=86705821https://www.theguardian.com/world/2020/apr/16/healthcare-workers-screened-covid-19-every-week-infectious-unethicalhttps://www.nytimes.com/2020/04/17/well/live/coronavirus-contagion-spead-clothes-shoes-hair-newspaper-packages-mail-infectious.html?utm_source=pocket&utm_medium=email&utm_campaign=pockethitshttps://www.nytimes.com/2020/04/16/health/coronavirus-asthma-risk.html?smtyp=cur&smid=tw-nythealthhttps://www.nytimes.com/2020/04/14/health/disinfectant-coronavirus.html?smid=tw-nythealth&smtyp=curhttps://www.nytimes.com/interactive/2020/health/coronavirus-best-face-masks.htmlhttps://www.politico.com/news/2020/04/15/dialysis-kidney-coronavirus-188840https://www.nytimes.com/2020/04/16/health/coronavirus-obesity-higher-risk.htmlhttps://www.nytimes.com/interactive/2020/04/14/science/coronavirus-transmission-cough-6-feet-ar-ul.htmlhttps://www.sciencemag.org/news/2020/04/how-does-coronavirus-kill-clinicians-trace-ferocious-rampage-through-body-brain-toes#
-
1. Shi Y, Zhang X, Mu K et al. D3Targets-2019-nCoV: a webserver
for predicting drug targets and formulti-target and multi-site
based virtual screening against COVID-19. Acta Pharm Sin B
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318328
2. Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin
system at the heart of COVID-19pandemic. Biochimie 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305506
3. Kim D, Lee JY, Yang JS et al. The Architecture of SARS-CoV-2
Transcriptome. Cell
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330414
4. Monteil V, Kwon H, Prado P et al. Inhibition of SARS-CoV-2
Infections in Engineered Human TissuesUsing Clinical-Grade Soluble
Human ACE2. Cell 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32333836
5. Macchiagodena M, Pagliai M, Procacci P. Identification of
Potential Binders of the Main Protease3CL(pro) of the COVID-19 via
Structure-Based Ligand Design and Molecular Modeling. Chem.
Phys.Lett. 2020:137489.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32313296
6. Ekins S, Mottin M, Ramos P et al. Deja vu: stimulating open
drug discovery for SARS-CoV-2. DrugDiscov Today 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320852
7. Jogalekar MP, Veerabathini A, Gangadaran P. Novel 2019
coronavirus: Genome structure, clinicaltrials, and outstanding
questions. Exp. Biol. Med. (Maywood)
2020:1535370220920540.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306751
8. Jackson DJ, Busse WW, Bacharier LB et al. Association of
Respiratory Allergy, Asthma andExpression of the SARS-CoV-2
Receptor, ACE2. J Allergy Clin Immunol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333915
9. Joshi RS, Jagdale SS, Bansode SB et al. Discovery of
Potential Multi-Target-Directed Ligands byTargeting Host-specific
SARS-CoV-2 Structurally Conserved Main Protease($). J Biomol Struct
Dyn2020:1-16. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329408
10. Jaimes JA, Andre NM, Chappie JS et al. Phylogenetic Analysis
and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an
Evolutionary Distinct and Proteolytically Sensitive Activation
Loop. J.Mol. Biol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320687
11. Pachetti M, Marini B, Benedetti F et al. Emerging SARS-CoV-2
mutation hot spots include a novelRNA-dependent-RNA polymerase
variant. J Transl Med 2020;
18:179.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321524
12. Sportelli MC, Izzi M, Kukushkina EA et al. Can
Nanotechnology and Materials Science Help the Fightagainst
SARS-CoV-2? Nanomaterials (Basel) 2020; 10.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32326343
Biomarkers - Genetics1. Zhang L, Pang R, Xue X et al.
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of
six
donors who have recovered from COVID-19. Aging (Albany NY) 2020;
12.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320384
2. Ganji A, Farahani I, Khansarinejad B et al. Increased
expression of CD8 marker on T-cells in COVID-19patients. Blood
Cells Mol. Dis. 2020; 83:102437.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32325421
3. Xiang F, Wang X, He X et al. Antibody Detection and Dynamic
Characteristics in Patients with COVID-19. Clin Infect Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306047
4. Xiao AT, Tong YX, Zhang S. Profile of RT-PCR for SARS-CoV-2:
a preliminary study from 56 COVID-19patients. Clin Infect Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306036
5. Nicco C, Paule A, Konturek P, Edeas M. From Donor to Patient:
Collection, Preparation andCryopreservation of Fecal Samples for
Fecal Microbiota Transplantation. Diseases 2020;
8.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326509
6. Baek YH, Um J, Antigua KJC et al. Development of a reverse
transcription-loop-mediated isothermalamplification as a rapid
early-detection method for novel SARS-CoV-2. Emerg Microbes Infect
2020:1-31. http://www.ncbi.nlm.nih.gov/pubmed/?term=32306853
7. Yongchen Z, Shen H, Wang X et al. Different longitudinal
patterns of nucleic acid and serology testingresults based on
disease severity of COVID-19 patients. Emerg Microbes Infect
2020:1-14.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306864
8. Wang H, Li X, Li T et al. The genetic sequence, origin, and
diagnosis of SARS-CoV-2. Eur J ClinMicrobiol Infect Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32333222
9. De Virgilio A, Pellini R, Mercante G et al. Who should
perform the rhinopharyngeal swab in COVID-19positive patients? Head
Neck 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32329138
10. Wang X, Tan L, Wang X et al. Comparison of nasopharyngeal
and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients
received tests with both specimens simultaneously. Int J Infect
Dis2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315809
11. Lu R, Wu X, Wan Z et al. A Novel Reverse Transcription
Loop-Mediated Isothermal AmplificationMethod for Rapid Detection of
SARS-CoV-2. Int J Mol Sci 2020;
21.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325642
12. Tersalvi G, Vicenzi M, Calabretta D et al. Elevated troponin
in patients with Coronavirus Disease 2019(COVID-19): possible
mechanisms. J. Card. Fail. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315733
13. Paoli D, Pallotti F, Colangelo S et al. Study of SARS-CoV-2
in semen and urine samples of a volunteerwith positive
naso-pharyngeal swab. J. Endocrinol. Invest. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32329026
14. Li Y, Hu Y, Yu Y et al. Positive result of Sars-Cov-2 in
faeces and sputum from discharged patientwith COVID-19 in Yiwu,
China. J Med Virol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311109
15. Yong G, Yi Y, Tuantuan L et al. Evaluation of the auxiliary
diagnostic value of antibody assays for thedetection of novel
coronavirus (SARS-CoV-2). J Med Virol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320064
16. Sullivan PS, Sailey C, Guest JL et al. Detection of
SARS-CoV-2 RNA and Antibodies in DiverseSamples: Protocol to
Validate the Sufficiency of Provider-Observed, Home-Collected
Blood, Saliva,and Oropharyngeal Samples. JMIR Public Health
Surveill 2020;
6:e19054.http://www.ncbi.nlm.nih.gov/pubmed/?term=32310815
-
17. Lorusso A, Calistri P, Mercante MT et al. A "One-Health"
approach for diagnosis and molecularcharacterization of SARS-CoV-2
in Italy. One Health 2020:100135.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32313828
18. Fan Q, Pan Y, Wu Q et al. Anal swab findings in an infant
with COVID-19. Pediatr Investig 2020; 4:48-50.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328338
19. Huang X, Wei F, Yang Z et al. Lactose Dehydrogenase in
Patients with Severe COVID-19: A Meta-Analysis of Retrospective
Study. Prehosp. Disaster Med.
2020:1-9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326988
20. Dohla M, Boesecke C, Schulte B et al. Rapid point-of-care
testing for SARS-CoV-2 in a communityscreening setting shows low
sensitivity. Public Health 2020;
182:170-172.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334183
21. Lippi G, Henry BM. Eosinophil count in severe coronavirus
disease 2019 (COVID-19). QJM
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315429
22. Qian GQ, Zhang X, Ma AHY, Yang NB. Response letter to
Eosinophil count in severe coronavirusdisease 2019 (COVID-19). QJM
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315421
23. Bauer DC, Tay AP, Wilson LOW et al. Supporting pandemic
response using genomics andbioinformatics: a case study on the
emergent SARS-CoV-2 outbreak. Transbound Emerg Dis
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306500
24. Epstein J, Burnouf T. Points to consider in the preparation
and transfusion of COVID-19 convalescentplasma. Vox Sang 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32319102
Children1. Shi Y, Wang X, Liu G et al. A quickly, effectively
screening process of novel corona virus disease
2019 (COVID-19) in children in Shanghai, China. Ann Transl Med
2020; 8:241.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309388
2. Zhang J, Shuai L, Yu H et al. Acute stress, behavioural
symptoms and mood states among school-age children with
attention-deficit/hyperactive disorder during the COVID-19
outbreak. Asian JPsychiatr 2020; 51:102077.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315967
3. Leboulanger N, Sagardoy T, Akkari M et al. COVID-19 and ENT
Pediatric otolaryngology during theCOVID-19 pandemic. Guidelines of
the French Association of Pediatric Otorhinolaryngology (AFOP)and
French Society of Otorhinolaryngology (SFORL). Eur. Ann.
Otorhinolaryngol. Head Neck Dis.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312676
4. Hrusak O, Kalina T, Wolf J et al. Flash survey on severe
acute respiratory syndrome coronavirus-2infections in paediatric
patients on anticancer treatment. Eur. J. Cancer 2020;
132:11-16.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305831
5. Chiotos K, Hayes M, Kimberlin DW et al. Multicenter initial
guidance on use of antivirals for childrenwith COVID-19/SARS-CoV-2.
J Pediatric Infect Dis Soc 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32318706
6. Kan MJ, Grant LMC, Muna MA, Greenhow TL. Fever without a
source in a young infant due to SARS-CoV-2. J Pediatric Infect Dis
Soc 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32318729
7. Ogimi C, Kim YJ, Martin ET et al. What's New With the Old
Coronaviruses? J Pediatric Infect Dis Soc2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314790
8. Castagnoli R, Votto M, Licari A et al. Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Infection in
Children and Adolescents: A Systematic Review. JAMA Pediatr
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320004
9. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem
associated with COVID-19 in an 8-year-old girl: A diagnostic clue?
Pediatr. Dermatol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315079
10. Shen Q, Wang M, Che R et al. Consensus recommendations for
the care of children receivingchronic dialysis in association with
the COVID-19 epidemic. Pediatr. Nephrol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333285
11. Licciardi F, Giani T, Baldini L et al. COVID-19 and what
pediatric rheumatologists should know: areview from a highly
affected country. Pediatr. Rheumatol. Online J. 2020;
18:35.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321540
12. Shen KL, Yang YH, Jiang RM et al. Updated diagnosis,
treatment and prevention of COVID-19 inchildren: experts' consensus
statement (condensed version of the second edition). World J
Pediatr2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333248
13. Levy E, Blumenthal J, Chiotos K, Dearani JA. COVID-19 FAQ's
in Pediatric Cardiac Surgery. World JPediatr Congenit Heart Surg
2020:2150135120924653.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32316830
Clinical Features1. Gianotti R, Veraldi S, Recalcati S et al.
Cutaneous Clinico-Pathological Findings in three COVID-19-
Positive Patients Observed in the Metropolitan Area of Milan,
Italy. Acta Derm. Venereol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315073
2. Singhania N, Bansal S, Singhania G. An Atypical Presentation
of Novel Coronavirus Disease 2019(COVID-19). Am. J. Med. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320693
3. Mustafa MWM. Audiological profile of asymptomatic Covid-19
PCR-positive cases. Am. J.Otolaryngol. 2020:102483.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307189
4. Salducci M, La Torre G. COVID-19 emergency in the cruise's
ship: a case report of conjunctivitis. Clin.Ter. 2020;
171:e189-e191.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323704
5. Hassan SA, Sheikh FN, Jamal S et al. Coronavirus (COVID-19):
A Review of Clinical Features,Diagnosis, and Treatment. Cureus
2020; 12:e7355.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328367
6. Rodriguez-Morales AJ, Rodriguez-Morales AG, Mendez CA,
Hernandez-Botero S. Tracing New ClinicalManifestations in Patients
with COVID-19 in Chile and Its Potential Relationship with the
SARS-CoV-
-
2 Divergence. Curr Trop Med Rep 2020:1-4.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323138047. Wee LE, Chan
YFZ, Teo NWY et al. The role of self-reported olfactory and
gustatory dysfunction as a
screening criterion for suspected COVID-19. Eur Arch
Otorhinolaryngol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32328771
8. Poggiali E, Ramos PM, Bastoni D et al. Abdominal Pain: A Real
Challenge in Novel COVID-19Infection. Eur J Case Rep Intern Med
2020; 7:001632.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32309266
9. Marzano AV, Genovese G, Fabbrocini G et al. Varicella-like
exanthem as a specific COVID-19-associated skin manifestation:
multicenter case series of 22 patients. J Am Acad Dermatol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305439
10. Shah M, Sachdeva M, Dodiuk-Gad RP. COVID-19 and Racial
Disparities. J Am Acad Dermatol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305444
11. Amatore F, Macagno N, Mailhe M et al. SARS-CoV-2 infection
presenting as a febrile rash. J Eur AcadDermatol Venereol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330336
12. Avellana Moreno R, Villa E, Avellana Moreno V et al.
Cutaneous manifestation of COVID-19 in images:A case report. J Eur
Acad Dermatol Venereol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330339
13. Hedou M, Carsuzaa F, Chary E et al. Comment on "Cutaneous
manifestations in COVID-19: a firstperspective " by Recalcati S. J
Eur Acad Dermatol Venereol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314436
14. Piccolo V, Neri I, Filippeschi C et al. Chilblain-like
lesions during COVID-19 epidemic: a preliminarystudy on 63
patients. J Eur Acad Dermatol Venereol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330334
15. Recalcati S, Barbagallo T, Frasin LA et al. Acral cutaneous
lesions in the Time of COVID-19. J Eur AcadDermatol Venereol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330324
16. Tammaro A, Adebanjo GAR, Parisella FR et al. Cutaneous
manifestations in COVID-19: theexperiences of Barcelona and Rome. J
Eur Acad Dermatol Venereol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330340
17. van Damme C, Berlingin E, Saussez S, Accaputo O. Acute
urticaria with pyrexia as the firstmanifestations of a COVID-19
infection. J Eur Acad Dermatol Venereol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329915
18. Loffredo L, Pacella F, Pacella E et al. Conjunctivitis and
COVID-19: a meta-analysis. J Med Virol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330304
19. Xie J, Ding C, Li J et al. Characteristics of Patients with
Coronavirus Disease (COVID-19) Confirmedusing an IgM-IgG Antibody
Test. J Med Virol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330303
20. Lovell N, Maddocks M, Etkind SN et al. Characteristics,
symptom management and outcomes of 101patients with COVID-19
referred for hospital palliative care. J Pain Symptom Manage
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325167
21. Richardson S, Hirsch JS, Narasimhan M et al. Presenting
Characteristics, Comorbidities, andOutcomes Among 5700 Patients
Hospitalized With COVID-19 in the New York City Area. JAMA
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320003
22. Hufert F, Spiegel M. Coronavirus: from common cold to severe
pulmonary failure: Chronology of apandemia. Monatsschr.
Kinderheilkd. 2020.
23. Genovese G, Colonna C, Marzano AV. Varicella-like exanthem
associated with COVID-19 in an 8-year-old girl: A diagnostic clue?
Pediatr. Dermatol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315079
CNS1. Das G, Mukherjee N, Ghosh S. Neurological Insights of
COVID-19 Pandemic. ACS Chem Neurosci
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=323202112. Brown
EE, Kumar S, Rajji TK et al. Anticipating and Mitigating the Impact
of the COVID-19 Pandemic
on Alzheimer's Disease and Related Dementias. Am J Geriatr
Psychiatry
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331845
3. Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological
Complications of Coronavirus Disease(COVID-19): Encephalopathy.
Cureus 2020; 12:e7352.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328364
4. Villalba NL, Maouche Y, Ortiz MBA et al. Anosmia and
Dysgeusia in the Absence of Other RespiratoryDiseases: Should
COVID-19 Infection Be Considered? Eur J Case Rep Intern Med 2020;
7:001641.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309267
5. Natoli S, Oliveira V, Calabresi P et al. Does SARS-Cov-2
invade the brain? Translational lessons fromanimal models. Eur. J.
Neurol. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333487
6. Sellner J, Taba P, Ozturk S, Helbok R. The need for
neurologists in the care of COVID-19 patients. Eur.J. Neurol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323891
7. Virani A, Rabold E, Hanson T et al. Guillain-Barre Syndrome
associated with SARS-CoV-2 infection.IDCases 2020:e00771.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32313807
8. Yan CH, Faraji F, Prajapati DP et al. Self-reported olfactory
loss associates with outpatient clinicalcourse in Covid-19. Int
Forum Allergy Rhinol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32329222
9. Sedaghat Z, Karimi N. Guillain Barre syndrome associated with
COVID-19 infection: A case report. J.Clin. Neurosci. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312628
10. Finsterer J, Stollberger C. Causes of hypogeusia/hyposmia in
SARS-CoV2 infected patients. J MedVirol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311107
11. Yashavantha Rao HC, Jayabaskaran C. The emergence of a novel
coronavirus (SARS-CoV-2) diseaseand their neuroinvasive propensity
may affect in COVID-19 patients. J Med Virol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320066
12. Spinato G, Fabbris C, Polesel J et al. Alterations in Smell
or Taste in Mildly Symptomatic OutpatientsWith SARS-CoV-2
Infection. JAMA 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320008
13. Klopfenstein T, Kadiane-Oussou NJ, Toko L et al. Features of
anosmia in COVID-19. Med Mal Infect2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305563
-
14. Tipton PW, Wszolek ZK. What can Parkinson's disease teach us
about COVID-19? Neurol. Neurochir.Pol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323862
15. Vinayachandran D, Balasubramanian S. Is Gustatory Impairment
the First Report of an OralManifestation in COVID-19? Oral Dis
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=3233348
Complications1. Casey K, Iteen A, Nicolini R, Auten J. COVID-19
pneumonia with hemoptysis: Acute segmental
pulmonary emboli associated with novel coronavirus infection. Am
J Emerg Med
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312574
2. Santoso A, Pranata R, Wibowo A et al. Cardiac injury is
associated with mortality and critically illpneumonia in COVID-19:
A meta-analysis. Am J Emerg Med
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331955
3. Zochios V, Brodie D, Charlesworth M, Parhar KK. Delivering
extracorporeal membrane oxygenation forpatients with COVID-19:
what, who, when and how? Anaesthesia
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319081
4. Notz Q, Herrmann J, Stumpner J et al. [Anesthesia and
intensive care ventilators: differences andusability in COVID-19
patients]. Anaesthesist 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32333024
5. Bassi M, Anile M, Pecoraro Y et al. BEDSIDE
TRANSCERVICAL-TRANSTRACHEAL POST-INTUBATION INJURY REPAIR IN A
COVID-19 PATIENT. Ann Thorac Surg
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333850
6. Fogarty H, Townsend L, Ni Cheallaigh C et al. COVID-19
Coagulopathy in Caucasian patients. Br. J.Haematol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330308
7. Poissy J, Goutay J, Caplan M et al. Pulmonary Embolism in
COVID-19 Patients: Awareness of anIncreased Prevalence. Circulation
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330083
8. Zhou Y, Han T, Chen J et al. Clinical and Autoimmune
Characteristics of Severe and Critical Caseswith COVID-19. Clin
Transl Sci 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315487
9. Li J, Wang X, Chen J et al. COVID-19 infection may cause
ketosis and ketoacidosis. Diabetes Obes.Metab. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314455
10. Zhao M. Cytokine storm and immunomodulatory therapy in
COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.
Int J Antimicrob Agents 2020:105982.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305588
11. Sultan I, Habertheuer A, Usman AA et al. The role of
extracorporeal life support for patients withCOVID-19: Preliminary
results from a statewide experience. J. Card. Surg.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333431
12. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in
coronavirus infected patients: COVID-19,SARS-CoV-1, MERS-CoV and
lessons from the past. J Clin Virol 2020;
127:104362.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305883
13. Piva S, Filippini M, Turla F et al. Clinical presentation
and initial management critically ill patients withsevere acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
Brescia, Italy. J CritCare 2020; 58:29-33.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330817
14. Llitjos JF, Leclerc M, Chochois C et al. High incidence of
venous thromboembolic events inanticoagulated severe COVID-19
patients. J Thromb Haemost
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320517
15. Foch E, Allou N, Vitry T et al. Pulmonary embolism in
returning traveler with COVID-19 pneumonia. JTravel Med 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330267
16. Marone EM, Rinaldi LF. Upsurge of deep venous thrombosis in
patients affected by COVID-19:preliminary data and possible
explanations. J Vasc Surg Venous Lymphat Disord
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305586
17. Ullah W, Saeed R, Sarwar U et al. COVID-19 complicated by
Acute Pulmonary Embolism and Right-Sided Heart Failure. JACC Case
Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313884
18. Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and
intracerebral haemorrhage: causative orcoincidental? New Microbes
New Infect 2020; 35:100669.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322398
19. Berhes M, Fabian A, Laszlo I et al. [Advanced organ support
and life-sustaining therapies in criticallyill COVID-19 infected
patients]. Orv. Hetil. 2020; 161:704-709.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324366
20. Laszlo I, Molnar C, Koszta G et al. [Special aspects of
in-hospital resuscitation of COVID-19 patients].Orv. Hetil. 2020;
161:710-712. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324367
21. Vegh T, Laszlo I, Juhasz M et al. [Practical aspects of care
for a critically ill COVID-19 infected patientin need of
respiratory support]. Orv. Hetil. 2020; 161:678-684.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324362
22. Song J, Kang S, Choi SW et al. Coronavirus Disease 19
(COVID-19) complicated with pneumonia in apatient with rheumatoid
arthritis receiving conventional disease-modifying antirheumatic
drugs.Rheumatol. Int. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314010
Cured – recovered1. Chintalapudi N, Battineni G, Amenta F.
COVID-19 virus outbreak forecasting of registered and
recovered cases after sixty day lockdown in Italy: A data driven
model approach. J Microbiol ImmunolInfect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305271
Cardiovascular disease
-
1. Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular
complications in COVID-19. Am J EmergMed 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317203
2. Santoso A, Pranata R, Wibowo A et al. Cardiac injury is
associated with mortality and critically illpneumonia in COVID-19:
A meta-analysis. Am J Emerg Med
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331955
3. Alifano M, Alifano P, Forgez P, Iannelli A. Renin-angiotensin
system at the heart of COVID-19pandemic. Biochimie 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305506
4. Mahmud E, Dauerman HL, Welt FG et al. Management of Acute
Myocardial Infarction During theCOVID-19 Pandemic. Catheter.
Cardiovasc. Interv. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311816
5. DeFilippis EM, Farr MA, Givertz MM. Challenges in Heart
Transplantation in the Era of COVID-19.Circulation 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314596
6. Duffy EY, Cainzos-Achirica M, Michos ED. Primary and
Secondary Prevention of CardiovascularDisease in the Era of the
Coronavirus Pandemic. Circulation
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32310675
7. Zhu H, Rhee JW, Cheng P et al. Cardiovascular Complications
in Patients with COVID-19:Consequences of Viral Toxicities and Host
Immune Response. Curr Cardiol Rep 2020;
22:32.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318865
8. Aggarwal G, Lippi G, Michael Henry B. Cerebrovascular disease
is associated with an increaseddisease severity in patients with
Coronavirus Disease 2019 (COVID-19): A pooled analysis ofpublished
literature. Int. J. Stroke 2020:1747493020921664.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32310015
9. Brojakowska A, Narula J, Shimony R, Bander J. Clinical
Implications of SARS-Cov2 Interaction withRenin Angiotensin System.
J Am Coll Cardiol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305401
10. Mahmud E, Dauerman HL, Welt FG et al. Management of Acute
Myocardial Infarction During theCOVID-19 Pandemic. J Am Coll
Cardiol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330544
11. Tersalvi G, Vicenzi M, Calabretta D et al. Elevated troponin
in patients with Coronavirus Disease 2019(COVID-19): possible
mechanisms. J. Card. Fail. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315733
12. Aghagoli G, Gallo Marin B, Soliman LB, Sellke FW. Cardiac
involvement in COVID-19 patients: Riskfactors, predictors, and
complications: A review. J. Card. Surg.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306491
13. Wang NC, Jain SK, Estes NAM, 3rd et al. Priority plan for
invasive cardiac electrophysiologyprocedures during the coronavirus
disease 2019 (COVID-19) pandemic. J Cardiovasc Electrophysiol2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323382
14. Dabbagh MF, Aurora L, D'Souza P et al. Cardiac Tamponade
Secondary to COVID-19. JACC Case Rep2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328588
15. Rodriguez-Leor O, Cid-Alvarez B. STEMI care during COVID-19:
losing sight of the forest for the trees.JACC Case Rep 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328589
16. Sorgente A, Capulzini L, Brugada P. The Known into the
Unknown: Brugada syndrome and COVID-19.JACC Case Rep 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32310242
17. Song JC, Wang G, Zhang W et al. Chinese expert consensus on
diagnosis and treatment ofcoagulation dysfunction in COVID-19. Mil
Med Res 2020; 7:19.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307014
18. Li JW, Han TW, Woodward M et al. The impact of 2019 novel
coronavirus on heart injury: A systemicreview and Meta-analysis.
Prog Cardiovasc Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305557
19. Couper K, Taylor-Phillips S, Grove A et al. COVID-19 in
cardiac arrest and infection risk to rescuers: asystematic review.
Resuscitation 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32325096
Diagnosis1. Borghetti A, Ciccullo A, Visconti E et al. COVID-19
diagnosis does not rule out other concomitant
diseases. Eur. J. Clin. Invest. 2020:e13241.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323077172. Chang TH, Wu
JL, Chang LY. Clinical characteristics and diagnostic challenges of
pediatric COVID-
19: A systematic review and meta-analysis. J Formos Med Assoc
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307322
DM -MS-Obesity1. Hanif S, Ali SN, Hassanein M et al. Managing
People with Diabetes Fasting for Ramadan During the
COVID-19 Pandemic: A South Asian Health Foundation Update.
Diabet. Med.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333691
2. Banerjee M, Chakraborty S, Pal R. Diabetes self-management
amid COVID-19 pandemic. DiabetesMetab Syndr 2020; 14:351-354.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311652
3. Cure E, Cumhur Cure M. Angiotensin-converting enzyme
inhibitors and angiotensin receptorblockers may be harmful in
patients with diabetes during COVID-19 pandemic. Diabetes Metab
Syndr2020; 14:349-350.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311651
4. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated
with increased mortality and severity ofdisease in COVID-19
pneumonia - A systematic review, meta-analysis, and
meta-regression.Diabetes Metab Syndr 2020; 14:395-403.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32334395
5. Ceriello A, Stoian AP, Rizzo M. COVID-19 and diabetes
management: What should be considered?Diabetes Res Clin Pract
2020:108151. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305399
6. Kasuki L, Gadelha MR. Letter to the Editor: "Our Response to
COVID-19 as Endocrinologists andDiabetologists". J. Clin.
Endocrinol. Metab. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315031
-
7. Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients
with COVID-19 infection are at higher risk ofICU admission and poor
short-term outcome. J Clin Virol 2020;
127:104354.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305882
8. Angelidi AM, Belanger MJ, Mantzoros CS. COVID-19 and diabetes
mellitus: what we know, how ourpatients should be treated now, and
what should happen next. Metabolism
2020:154245.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320742
Elderly1. Tay HS, Harwood R. Atypical presentation of COVID-19
in a frail older person. Age Ageing 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323153862. Etard JF,
Vanhems P, Atlani-Duault L, Ecochard R. Potential lethal outbreak
of coronavirus disease
(COVID-19) among the elderly in retirement homes and long-term
facilities, France, March 2020.Euro Surveill 2020; 25.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317051
3. Cudjoe E, Abdullah A. Drawing on Kinship Care Support for
Older People during a Pandemic (COVID-19): Practice Considerations
for Social Workers in Ghana. J Gerontol Soc Work
2020:1-3.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326853
Epidemiology1. Tang L, Ye Z, Huang Z et al. Coronavirus disease
2019 (COVID-19): two case reports from a family
cluster. Ann Palliat Med 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323120642. Shi Y, Wang X,
Liu G et al. A quickly, effectively screening process of novel
corona virus disease
2019 (COVID-19) in children in Shanghai, China. Ann Transl Med
2020; 8:241.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309388
3. Sokouti M, Sadeghi R, Pashazadeh S et al. Comparative Global
Epidemiological Investigation ofSARS-CoV-2 and SARS-CoV Diseases
Using Meta-MUMS Tool Through Incidence, Mortality, andRecovery
Rates. Arch Med Res 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32331787
4. Zhang J, Wu S, Xu L. Asymptomatic carriers of COVID-19 as a
concern for disease prevention andcontrol: more testing, more
follow-up. Biosci Trends 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32321904
5. Bekiros S, Kouloumpou D. SBDiEM: A new Mathematical model of
Infectious Disease Dynamics.Chaos Solitons Fractals 2020:109828.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327901
6. Fanelli D, Piazza F. Analysis and forecast of COVID-19
spreading in China, Italy and France. ChaosSolitons Fractals 2020;
134:109761. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308258
7. Zhang X, Ma R, Wang L. Predicting turning point, duration and
attack rate of COVID-19 outbreaks inmajor Western countries. Chaos
Solitons Fractals 2020:109829.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32313405
8. Khachfe HH, Chahrour M, Sammouri J et al. An Epidemiological
Study on COVID-19: A RapidlySpreading Disease. Cureus 2020;
12:e7313. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313754
9. Gemelli NA. MANAGEMENT OF COVID-19 OUTBREAK IN ARGENTINA: THE
BEGINNING. DisasterMed Public Health Prep 2020:1-6.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317041
10. Tiwari S, Kumar S, Guleria K. Outbreak trends of CoronaVirus
(COVID-19) in India: A Prediction.Disaster Med Public Health Prep
2020:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317044
11. Liu Y, Gu Z, Xia S et al. What are the Underlying
Transmission Patterns of COVID-19 Outbreak? - AnAge-specific Social
Contact Characterization. EClinicalMedicine
2020:100354.http://www.ncbi.nlm.nih.gov/pubmed/?term=32313879
12. Muniz-Rodriguez K, Chowell G, Cheung CH et al. Doubling Time
of the COVID-19 Epidemic byProvince, China. Emerg Infect Dis 2020;
26. http://www.ncbi.nlm.nih.gov/pubmed/?term=32330410
13. Muniz-Rodriguez K, Fung IC, Ferdosi SR et al. Severe Acute
Respiratory Syndrome Coronavirus 2Transmission Potential, Iran,
2020. Emerg Infect Dis 2020; 26.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320641
14. Park SY, Kim YM, Yi S et al. Coronavirus Disease Outbreak in
Call Center, South Korea. Emerg InfectDis 2020; 26.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324530
15. Tobias A, Molina T. Is temperature reducing the transmission
of COVID-19 ? Environ. Res. 2020;186:109553.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330766
16. Drame M, Godaert L, Callixte KT et al. Coping with the
COVID-19 crisis in Sub-Saharan Africa: let usnot leave older people
behind! Eur. Geriatr. Med. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323250
17. Sebastiani G, Massa M, Riboli E. Covid-19 epidemic in Italy:
evolution, projections and impact ofgovernment measures. Eur. J.
Epidemiol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306149
18. Chattu VK, Adisesh A, Yaya S. Canada's role in strengthening
global health security during theCOVID-19 pandemic. Glob Health Res
Policy 2020; 5:16.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328533
19. Kumar M, Kuroda K, Dhangar K. The most eagerly awaited
summer of the Anthropocene: Aperspective of SARS-CoV-2 decay and
seasonal change. Groundw Sustain Dev
2020:100400.http://www.ncbi.nlm.nih.gov/pubmed/?term=32322654
20. Stubinger J, Schneider L. Epidemiology of Coronavirus
COVID-19: Forecasting the Future Incidencein Different Countries.
Healthcare (Basel) 2020; 8.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32326512
21. Gupta N, Praharaj I, Bhatnagar T et al. Severe acute
respiratory illness surveillance for coronavirusdisease 2019,
India, 2020. Indian J Med Res 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317406
22. Khanna RC, Cicinelli MV, Gilbert SS et al. COVID-19
pandemic: Lessons learned and future directions.Indian J Ophthalmol
2020; 68:703-710.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317432
23. Yeo YY, Ganem B. The Importance of Initial Response During
Outbreaks: A Perspective fromObservations on COVID-19. Infect
Control Hosp Epidemiol
2020:1-6.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307029
-
24. Yang C, Qiu X, Fan H et al. Coronavirus disease 2019:
reassembly attack of coronavirus. Int. J.Environ. Health Res.
2020:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32316751
25. Qeadan F, Honda T, Gren LH et al. Naive Forecast for
COVID-19 in Utah Based on the South Koreaand Italy Models-the
Fluctuation between Two Extremes. Int J Environ Res Public Health
2020; 17.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316165
26. Du W, Han S, Li Q, Zhang Z. Epidemic update of COVID-19 in
Hubei Province compared with otherregions in China. Int J Infect
Dis 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32325276
27. He D, Zhao S, Lin Q et al. The relative transmissibility of
asymptomatic cases among close contacts.Int J Infect Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315808
28. Hu Z, Cui Q, Han J et al. Evaluation and prediction of the
COVID-19 variations at different inputpopulation and quarantine
strategies, a case study in Guangdong province, China. Int J Infect
Dis2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334117
29. Napoli PE, Nioi M. Global Spread of Coronavirus Disease 2019
and Malaria: An EpidemiologicalParadox in the Early Stage of A
Pandemic. J Clin Med 2020; 9.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32316118
30. McDermott CV, Alicic RZ, Harden N et al. Put a lid on it:
Are faecal bio-aerosols a route oftransmission for SARS-CoV-2? J
Hosp Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315667
31. Kenyon C. Flattening-the-curve associated with reduced
COVID-19 case fatality rates- an ecologicalanalysis of 65
countries. J Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305488
32. Tu H, Tu S, Gao S et al. The epidemiological and clinical
features of COVID-19 and lessons from thisglobal infectious public
health event. J Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315723
33. La Maestra S, Abbondandolo A, De Flora S. Epidemiological
trends of COVID-19 epidemic in Italyduring March 2020. From 1,000
to 100,000 cases. J Med Virol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314804
34. Aluga MA. Coronavirus Disease 2019 (COVID-19) in Kenya:
Preparedness, response andtransmissibility. J Microbiol Immunol
Infect 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32331980
35. Chen FM, Feng MC, Chen TC et al. Big data integration and
analytics to prevent a potential hospitaloutbreak of COVID-19 in
Taiwan. J Microbiol Immunol Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327328
36. Chung YT, Yeh CY, Shu YC et al. Continuous temperature
monitoring by a wearable device for earlydetection of febrile
events in the SARS-CoV-2 outbreak in Taiwan, 2020. J Microbiol
Immunol Infect2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32331981
37. Huang HT, Chen TC, Liu TY et al. How to prevent outbreak of
a hospital-affiliated dementia day-carefacility in the pandemic
COVID-19 infection in Taiwan. J Microbiol Immunol Infect
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305270
38. Makurumidze R. Coronavirus-19 disease (COVID-19): A case
series of early suspected casesreported and the implications
towards the response to the pandemic in Zimbabwe. J
MicrobiolImmunol Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305269
39. Miglietta A, Levi M. Documented early circulation of
Coronavirus Disease 2019 (COVID-19) in Florida,USA, since February
2020. J Public Health (Oxf) 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307519
40. Laurencin CT, McClinton A. The COVID-19 Pandemic: a Call to
Action to Identify and Address Racialand Ethnic Disparities. J
Racial Ethn Health Disparities 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306369
41. Pineda VS, Corburn J. Disability, Urban Health Equity, and
the Coronavirus Pandemic: PromotingCities for All. J. Urban Health
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328866
42. Abdullah JM, Wan Ismail WFN, Mohamad I et al. A Critical
Appraisal of COVID-19 in Malaysia andBeyond. Malays. J. Med. Sci.
2020; 27:1-9. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308536
43. Abduljalil JM, Abduljalil BM. Epidemiology, genome, and
clinical features of the pandemic SARS-CoV-2: a recent view. New
Microbes New Infect 2020; 35:100672.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322400
44. Hamid S, Mir MY, Rohela GK. Novel coronavirus disease
(COVID-19): a pandemic (epidemiology,pathogenesis and potential
therapeutics). New Microbes New Infect 2020;
35:100679.http://www.ncbi.nlm.nih.gov/pubmed/?term=32322401
45. Waris A, Atta UK, Ali M et al. COVID-19 outbreak: current
scenario of Pakistan. New Microbes NewInfect 2020; 35:100681.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322403
46. Columbus C, Brust KB, Arroliga AC. 2019 novel coronavirus:
an emerging global threat. Proc. (Bayl.Univ. Med. Cent.) 2020;
33:209-212. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313463
47. Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L et al.
Does the pathogenesis of SAR-CoV-2virus decrease at high-altitude?
Respir. Physiol. Neurobiol.
2020:103443.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333993
48. Saez M, Tobias A, Varga D, Barcelo MA. Effectiveness of the
measures to flatten the epidemic curveof COVID-19. The case of
Spain. Sci Total Environ 2020;
727:138761.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330703
49. Tomar A, Gupta N. Prediction for the spread of COVID-19 in
India and effectiveness of preventivemeasures. Sci Total Environ
2020; 728:138762.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32334157
50. Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease
2019 (COVID-19) Pandemic. Tohoku J.Exp. Med. 2020; 250:271-278.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32321874
51. Torres-Roman JS, Kobiak IC, Valcarcel B et al. The
reproductive number R0 of COVID-19 in Peru: Anopportunity for
effective changes. Travel Med Infect Dis
2020:101689.http://www.ncbi.nlm.nih.gov/pubmed/?term=32325120
52. Yezli S, Khan A. COVID-19 social distancing in the Kingdom
of Saudi Arabia: Bold measures in theface of political, economic,
social and religious challenges. Travel Med Infect Dis
2020:101692.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330561
53. Edrada EM, Lopez EB, Villarama JB et al. First COVID-19
infections in the Philippines: a case report.Trop Med Health 2020;
48:21. http://www.ncbi.nlm.nih.gov/pubmed/?term=32308532
54. Chowdhury A, Jahan N, Wang S. One month of the novel
coronavirus 2019 outbreak: Is it still athreat? Virusdisease
2020:1-5. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313823
-
55. Yang WZ. [Thoughts of the COVID-19 outbreak phases changed
from emergency response tocombination of emergency response and
regular prevention and control]. Zhonghua Liu Xing BingXue Za Zhi
2020; 41:E045.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312021
Gastro-enterology-hepatology1. Sethi A, Swaminath A, Latorre M
et al. Donning a new approach to the practice of
gastroenterology:
perspectives from the COVID-19 pandemic epicenter. Clin
Gastroenterol Hepatol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330565
2. Wei XS, Wang X, Niu YR et al. Diarrhea is associated with
prolonged symptoms and viral carriage inCOVID-19. Clin
Gastroenterol Hepatol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311512
3. Poggiali E, Ramos PM, Bastoni D et al. Abdominal Pain: A Real
Challenge in Novel COVID-19Infection. Eur J Case Rep Intern Med
2020; 7:001632.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32309266
4. D'Amico F, Peyrin-Biroulet L, Danese S. Inflammatory bowel
diseases and COVID-19: the invisibleenemy. Gastroenterology 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305331
5. Rodriguez-Lago I, Ramirez de la Piscina P, Elorza A et al.
Characteristics and prognosis of patientswith inflammatory bowel
disease during the SARS-CoV-2 pandemic in the Basque Country
(Spain).Gastroenterology 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330477
6. An P, Huang X, Wan X et al. ERCP during the pandemic of
COVID-19 in Wuhan, China. GastrointestEndosc 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305345
7. Occhipinti V, Pastorelli L. Challenges in the Care of IBD
Patients During the CoViD-19 Pandemic:Report From a "Red Zone" Area
in Northern Italy. Inflamm. Bowel Dis.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314792
8. Zhang H, Li HB, Lyu JR et al. Specific ACE2 Expression in
Small Intestinal Enterocytes may CauseGastrointestinal Symptoms and
Injury after 2019-nCoV Infection. Int J Infect Dis
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311451
9. Hara T, Yamamoto C, Sawada R et al. Infection risk in a
gastroenterological ward during a nosocomialCOVID-19 infection
event. J Med Virol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32320062
10. Karimi-Sari H, Rezaee-Zavareh MS. COVID-19 and viral
hepatitis elimination programs: Are westepping backward? Liver Int
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319207
11. Hajifathalian K, Mahadev S, Schwartz RE et al. SARS-COV-2
infection (coronavirus disease 2019) forthe gastrointestinal
consultant. World J. Gastroenterol. 2020;
26:1546-1553.http://www.ncbi.nlm.nih.gov/pubmed/?term=32327904
12. Zhen L, Lin T, Zhao ML et al. [Management strategy for the
resumption of regular diagnosis andtreatment in gastrointestinal
surgery department during the outbreak of coronavirus disease
2019(COVID-19)]. Zhonghua Wei Chang Wai Ke Za Zhi 2020;
23:321-326.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306596
13. Zhu L, Cai MY, Shi Q et al. [Analysis of selective endoscopy
results during the epidemic ofcoronavirus disease 2019 (COVID-19)].
Zhonghua Wei Chang Wai Ke Za Zhi 2020;
23:327-331.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306597
Guidelines -Consensus1. Zochios V, Brodie D, Charlesworth M,
Parhar KK. Delivering extracorporeal membrane oxygenation for
patients with COVID-19: what, who, when and how? Anaesthesia
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319081
2. Kranke P, Weibel S, Sitter M et al. Obstetric Anesthesia
during the SARS-CoV-2 Pandemic - A BriefOverview of Published
Recommendations for Action by National and International
SpecialistSocieties and Committees. Anasthesiologie Intensivmedizin
Notfallmedizin Schmerztherapie 2020;55:266-274.
3. Ghelichkhani P, Esmaeili M. Prone Position in Management of
COVID-19 Patients; a Commentary. ArchAcad Emerg Med 2020; 8:e48.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32309812
4. Mahmoudjafari Z, Alexander M, Roddy J et al. American Society
for Transplantation and CellularTherapy Pharmacy Special Interest
Group Position Statement on Pharmacy Practice Managementand
Clinical Management for COVID-19 in Hematopoietic Cell Transplant
and Cellular TherapyPatients in the United States. Biol Blood
Marrow Transplant 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305359
5. Mahmoudjafari Z, Alexander M, Roddy J et al. American Society
for Transplantation and CellularTherapy Pharmacy Special Interest
Group Position Statement on Pharmacy Practice Managementand
Clinical Management for COVID-19 in Hematopoietic Cell
Transplantation and Cellular TherapyPatients in the United States.
Biol Blood Marrow Transplant 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305359
6. Leboulanger N, Sagardoy T, Akkari M et al. COVID-19 and ENT
Pediatric otolaryngology during theCOVID-19 pandemic. Guidelines of
the French Association of Pediatric Otorhinolaryngology (AFOP)and
French Society of Otorhinolaryngology (SFORL). Eur. Ann.
Otorhinolaryngol. Head Neck Dis.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312676
7. Mattei A, Amy de la Breteque B, Crestani S et al. Guidelines
of clinical practice for the management ofswallowing disorders and
recent dysphonia in the context of the COVID-19 pandemic. Eur.
Ann.Otorhinolaryngol. Head Neck Dis. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32332004
8. Takhar A, Walker A, Tricklebank S et al. Recommendation of a
practical guideline for safetracheostomy during the COVID-19
pandemic. Eur Arch Otorhinolaryngol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314050
9. David AP, Russell MD, El-Sayed IH, Russell MS. Tracheostomy
guidelines developed at a largeacademic medical center during the
COVID-19 pandemic. Head Neck
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329926
-
10. Sengupta S, Honavar SG, Sachdev MS et al. All India
Ophthalmological Society - Indian Journal ofOphthalmology consensus
statement on preferred practices during the COVID-19 pandemic.
IndianJ Ophthalmol 2020; 68:711-724.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317433
11. Gallaher J, Charles A. Developing Guidelines for COVID-19
Management: A Moving Target. An invitedcommentary on "Evidence
Based Management Guideline for the COVID-19 Pandemic -
Reviewarticle". Int J Surg 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330655
12. Zic JA, Ai W, Akilov OE et al. (United States Cutaneous
Lymphoma Consortium) Recommendationsfor Treatment of Cutaneous
Lymphomas During the COVID-19 Pandemic. J Am Acad Dermatol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305443
13. Brojakowska A, Narula J, Shimony R, Bander J. Clinical
Implications of SARS-Cov2 Interaction withRenin Angiotensin System.
J Am Coll Cardiol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305401
14. Choi AD, Abbara S, Branch KR et al. Society of
Cardiovascular Computed Tomography guidance foruse of cardiac
computed tomography amidst the COVID-19 pandemic Endorsed by the
AmericanCollege of Cardiology. J. Cardiovasc. Comput. Tomogr. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317235
15. Kasperkiewicz M, Schmidt E, Fairley JA et al. Expert
recommendations for the management ofautoimmune bullous diseases
during the COVID-19 pandemic. J Eur Acad Dermatol Venereol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333823
16. Mirza AK. Perspectives on vascular surgical practice change
due to COVID-19 at a non-academictertiary care center. J. Vasc.
Surg. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32305385
17. Fulesdi B, Sarkany P, Szentkereszty Z, Gal J. [Challenges of
anesthesiology and intensive care forCOVID-19 infection. Practical
recommendation]. Orv. Hetil. 2020;
161:652-659.http://www.ncbi.nlm.nih.gov/pubmed/?term=32324357
18. Darwiche K, Ross B, Gesierich W et al. Recommendations for
Performing Bronchoscopy in Times ofthe COVID-19 Pandemic.
Pneumologie (Stuttgart, Germany) 2020.
19. Mitura K, Mysliwiec P, Rogula W et al. Guidelines for the
management of surgical departments in non-uniform hospitals during
the COVID-19 pandemic. Pol. Przegl. Chir. 2020;
92:48-59.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312919
20. Vivas D, Roldan V, Esteve-Pastor MA et al. [Recommendations
on antithrombotic treatment during theCOVID-19 pandemic. Position
statement of the Working Group on Cardiovascular Thrombosis of
theSpanish Society of Cardiology]. Rev. Esp. Cardiol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327870
21. Heffernan DS, Evans HL, Huston JM et al. Surgical Infection
Society Guidance for Operative and Peri-Operative Care of Adult
Patients Infected by the Severe Acute Respiratory Syndrome
Coronavirus-2(SARS-CoV-2). Surg Infect (Larchmt) 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32310715
22. Jain VK, Vaishya R. COVID-19 and orthopaedic surgeons: the
Indian scenario. Trop. Doct.2020:49475520921616.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32316857
23. Shen KL, Yang YH, Jiang RM et al. Updated diagnosis,
treatment and prevention of COVID-19 inchildren: experts' consensus
statement (condensed version of the second edition). World J
Pediatr2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32333248
Imaging1. Dane B, Brusca-Augello G, Kim D, Katz DS. Unexpected
Findings of Coronavirus Disease (COVID-19)
at the Lung Bases on Abdominopelvic CT. AJR Am J Roentgenol
2020:1-4.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319792
2. Jie B, Liu X, Suo H et al. Clinical and Dynamic Computed
Tomography Features of 24 Patients WithCoronavirus Disease 2019.
Can Assoc Radiol J
2020:846537120918834.http://www.ncbi.nlm.nih.gov/pubmed/?term=32306755
3. Jung EM, Stroszczynski C, Jung F. Contrast enhanced
ultrasonography (CEUS) to detect abdominalmicrocirculatory
disorders in severe cases of COVID-19 infection: First experience.
Clin. Hemorheol.Microcirc. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32333581
4. Ding X, Xu J, Zhou J, Long Q. Chest CT findings of COVID-19
pneumonia by duration of symptoms.Eur J Radiol 2020; 127:109009.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32325282
5. Chen RC, Tan TT, Chan LP. Adapting to a new normal? 5 key
operational principles for a radiologyservice facing the COVID-19
pandemic. Eur Radiol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328761
6. Choi AD, Abbara S, Branch KR et al. Society of Cardiovascular
Computed Tomography guidance foruse of cardiac computed tomography
amidst the COVID-19 pandemic Endorsed by the AmericanCollege of
Cardiology. J. Cardiovasc. Comput. Tomogr. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317235
7. Zhang FY, Qiao Y, Zhang H. CT imaging of the COVID-19. J
Formos Med Assoc
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307320
8. Calvillo-Arguelles O, Abdel-Qadir H, Ky B et al. Modified
Routine Cardiac Imaging Surveillance of AdultCancer Patients and
Survivors during the COVID-19 Pandemic. JACC CardioOncol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309816
9. Fan N, Fan W, Li Z et al. Imaging characteristics of initial
chest computed tomography and clinicalmanifestations of patients
with COVID-19 pneumonia. Jpn J Radiol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32318916
10. Xia T, Li J, Gao J, Xu X. Small Solitary Ground-Glass Nodule
on CT as an Initial Manifestation ofCoronavirus Disease 2019
(COVID-19) Pneumonia. Korean J Radiol 2020;
21:545-549.http://www.ncbi.nlm.nih.gov/pubmed/?term=32323499
11. Lovas A, Hankovszky P, Korsos A et al. [Importance of
imaging diagnostics in the care of COVID-19infected patients]. Orv.
Hetil. 2020; 161:672-677.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324360
12. Shen Q, Wang M, Che R et al. Consensus recommendations for
the care of children receivingchronic dialysis in association with
the COVID-19 epidemic. Pediatr. Nephrol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333285
-
13. Moore S, Gardiner E. Point of care and intensive care lung
ultrasound: A reference guide forpractitioners during COVID-19.
Radiography (Lond) 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327383
14. Adair LB, 2nd, Ledermann EJ. Chest CT Findings of Early and
Progressive Phase COVID-19 Infectionfrom a US Patient. Radiol Case
Rep 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32313588
15. Li M. Chest CT features and their role in COVID-19. Radiol
Infect Dis
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309528
16. Gao J, Liu JQ, Wen HJ et al. The unsynchronized changes of
CT image and nucleic acid detection inCOVID-19: reports the two
cases from Gansu, China. Respir Res 2020;
21:96.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321530
17. Lim ZY, Khoo HW, Hui TCH et al. Variable computed tomography
appearances of COVID-19. SingaporeMed J 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312025
18. Abramowicz JS, Basseal JM. World Federation for Ultrasound
in Medicine and Biology PositionStatement: How to Perform a Safe
Ultrasound Examination and Clean Equipment in the Context
ofCOVID-19. Ultrasound Med. Biol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327199
Immune response1. Chiappelli F, Khakshooy A, Greenberg G.
CoViD-19 Immunopathology and Immunotherapy.
Bioinformation 2020; 16:219-222.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323082632.
Giamarellos-Bourboulis EJ, Netea MG, Rovina N et al. Complex Immune
Dysregulation in COVID-19
Patients with Severe Respiratory Failure. Cell Host Microbe
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32320677
3. Zhao M. Cytokine storm and immunomodulatory therapy in
COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.
Int J Antimicrob Agents 2020:105982.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305588
4. Zhu Z, Cai T, Fan L et al. Clinical value of
immune-inflammatory parameters to assess the severity ofcoronavirus
disease 2019. Int J Infect Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32334118
5. Quinti I, Lougaris V, Milito C et al. A possible role for B
cells in COVID-19?: Lesson from patients withAgammaglobulinemia. J
Allergy Clin Immunol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32333914
6. Xu B, Fan CY, Wang AL et al. Suppressed T cell-mediated
immunity in patients with COVID-19: aclinical retrospective study
in Wuhan, China. J Infect 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315725
Management – misc. diseases1. Sanz-Santos J, Rami-Porta R, Call
S. Lessons already learnt from the Covid-19 pandemic. J Thorac
Oncol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=323339792.
Fudulu DP, Angelini GD. Cardiac surgery in the time of the
coronavirus. J. Card. Surg. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323334373. Donato MF,
Invernizzi F, Lampertico P, Rossi G. HEALTH STATUS OF LIVER
TRANSPLANTED
PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE
SINGLE CENTEREXPERIENCE FROM MILAN. Clin Gastroenterol Hepatol
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32334081
4. Borchert A, Baumgarten L, Dalela D et al. Managing Urology
Consultations during COVID-19Pandemic: Application of a Structured
Care Pathway. Urology
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330531
5. Francis N, Dort J, Cho E et al. SAGES and EAES
recommendations for minimally invasive surgeryduring COVID-19
pandemic. Surg. Endosc. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323016
6. Tang K, Gaoshan J, Ahonsi B. Sexual and reproductive health
(SRH): a key issue in the emergencyresponse to the coronavirus
disease (COVID- 19) outbreak. Reprod Health 2020;
17:59.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326943
7. Abramovitz I, Palmon A, Levy D et al. Dental care during the
coronavirus disease 2019 (COVID-19)outbreak: operatory
considerations and clinical aspects. Quintessence Int. 2020;
51:418-429.http://www.ncbi.nlm.nih.gov/pubmed/?term=32328595
8. Vegh T, Laszlo I, Juhasz M et al. [Practical Aspects of
Anesthesia and Perioperative Care in COVID-19Infected Patients].
Orv. Hetil. 2020; 161:692-695.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324364
9. Day AT, Sher DJ, Lee RC et al. Head and neck oncology during
the COVID-19 pandemic:Reconsidering traditional treatment paradigms
in light of new surgical and other multilevel risks.Oral Oncol
2020; 105:104684.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330858
10. Wennmann DO, Dlugos CP, Hofschroer A et al. [Handling of
COVID-19 in the emergency department :Field report of the emergency
ward of the University Hospital Munster]. Med Klin
IntensivmedNotfmed 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322988
11. Glehen O, Kepenekian V, Bouche O et al. [Treatment of
primary and metastatic peritoneal tumors inthe Covid-19 pandemic
Proposals for prioritization from the RENAPE and BIG-RENAPE
groups].2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32328206
12. Richez C, Lazaro E, Lemoine M et al. Implications of
COVID-19 for the management of patients withinflammatory rheumatic
diseases. Joint Bone Spine 2020;
87:187-189.http://www.ncbi.nlm.nih.gov/pubmed/?term=32321633
13. Williams AC, Hill LJ. The 4 D's of Pellagra and Progress.
Int J Tryptophan Res 2020;13:1178646920910159.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327922
14. Yang L, Ren Y. Moral Obligation, Public Leadership, and
Collective Action for Epidemic Preventionand Control: Evidence from
the Corona Virus Disease 2019 (COVID-19) Emergency. Int J Environ
ResPublic Health 2020; 17.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32326618
15. Moravvej Z, Soltani Moghadam R, Ahmadian Yazdi A, Shahraki
K. COVID-19 Pandemic: OphthalmicPractice and Precautions in a
Tertiary Eye Hospital in Iran. Infect Control Hosp Epidemiol
2020:1-6.
-
http://www.ncbi.nlm.nih.gov/pubmed/?term=3232161116. Patel RJ,
Kejner A, McMullen C. Early Institutional Head and Neck Oncologic
and Microvascular
Surgery Practice Patterns Across the United States During the
SARS-CoV-2 (COVID19) Pandemic.Head Neck 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32329923
17. Baddour K, Kudrick LD, Neopaney A et al. Potential Impact of
the COVID-19 Pandemic on FinancialToxicity in Cancer Survivors.
Head Neck 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32329924
18. Bhattacharjee A, Patil VM, Dikshit R et al. Should we wait
or not? The preferable option for patientswith stage IV oral cancer
in COVID-19 pandemic. Head Neck
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32329953
19. Korobelnik JF, Loewenstein A, Eldem B et al. Guidance for
anti-VEGF intravitreal injections during theCOVID-19 pandemic.
Graefes Arch Clin Exp Ophthalmol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328757
20. Rassy E, Khoury-Abboud RM, Ibrahim N et al. What the
oncologist needs to know about COVID-19infection in cancer
patients. Future Oncol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323577
21. Kattan C, Badreddine H, Rassy E et al. The impact of the
coronavirus pandemic on the managementof cancer patients in
Lebanon: a single institutional experience. Future Oncol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32323581
22. Mattioli F, Fermi M, Ghirelli M et al. Tracheostomy in the
COVID-19 pandemic. Eur Arch Otorhinolaryngol2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322959
23. Barbieri L, Talavera Urquijo E, Parise P et al. Esophageal
oncologic surgery in SARS-CoV-2 (COVID-19)emergency. Dis. Esophagus
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32322892
24. Conforti C, Giuffrida R, Di Meo N, Zalaudek I. Management of
advanced melanoma in the COVID-19era. Dermatol Ther 2020:eacronym.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32323399
25. Spiess PE, Greene J, Keenan RJ et al. Meeting the challenge
of the 2019 novel coronavirus disease inpatients with cancer.
Cancer 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32324273
26. Sornsa-Ard T, Niramitsantiphong A, Liawrungrueang W.
Management of Traumatic Spinal Fracture inthe Coronavirus Disease
2019 Situation. Asian Spine J 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32326671
27. Setzen M, Svider PF, Pollock K. COVID-19 and rhinology: A
look at the future. Am. J. Otolaryngol.2020:102491.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32327218
28. Zhao N, Shi J, Zeng L, Yang S. [Clinical Characteristics and
Coping Strategies of Neoplasms with2019 Novel Coronavirus
Infection]. Zhongguo Fei Ai Za Zhi 2020;
23:261-266.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316713
29. Hedima EW, Adeyemi MS, Ikunaiye NY. Community Pharmacists:
On the frontline of health serviceagainst COVID-19 in LMICs. Res
Social Adm Pharm 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32317154
30. Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care
management practices at a designatedhospital during the COVID-19
epidemic. Res Social Adm Pharm
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32317153
31. Brough HA, Kalayci O, Sediva A et al. Managing childhood
allergies and immunodeficiencies duringrespiratory virus epidemics
- the 2020 COVID-19 pandemic. Pediatr. Allergy Immunol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32319129
32. Szmuda T, Ali S, Sloniewski P, Group NW. Telemedicine in
neurosurgery during the novel coronavirus(COVID-19) pandemic.
Neurol. Neurochir. Pol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32319670
33. MacIntyre CR, Heslop DJ. Public health, health systems and
palliation planning for COVID-19 on anexponential timeline. Med. J.
Aust. 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32319114
34. Silvestris N, Moschetta A, Paradiso A, Delvino A. COVID-19
Pandemic and the Crisis of HealthSystems: The Experience of the
Apulia Cancer Network and of the Comprehensive Cancer
CenterIstituto Tumori "Giovanni Paolo II" of Bari. Int J Environ
Res Public Health 2020;
17.http://www.ncbi.nlm.nih.gov/pubmed/?term=32316337
35. Patruno C, Fabbrocini G, Stingeni L, Napolitano M. The role
of occupational dermatology in the COVID-19 outbreak. Contact
Dermatitis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32319103
36. Cavicchiolo ME, Lolli E, Trevisanuto D, Baraldi E. Managing
a tertiary-level NICU in the time of COVID-19: Lessons learned from
a high-risk zone. Pediatr Pulmonol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315113
37. Werner MT, Carey RM, Albergotti WG et al. Impact of the
COVID-19 Pandemic on the Management ofHead and Neck Malignancies.
Otolaryngol Head Neck Surg
2020:194599820921413.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312163
38. Rameau A, Young VN, Amin MR, Sulica L. Flexible Laryngoscopy
and COVID-19. Otolaryngol HeadNeck Surg 2020:194599820921395.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312166
39. Aminian A, Kermansaravi M, Azizi S et al. Bariatric Surgical
Practice During the Initial Phase of COVID-19 Outbreak. Obes. Surg.
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32314249
40. Thomas P, Baldwin C, Bissett B et al. Physiotherapy
management for COVID-19 in the acute hospitalsetting: clinical
practice recommendations. J. Physiother. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312646
41. Gnanasegaran G, Williams J, Huang HL, Bomanji JB.
Coronavirus (COVID-19) Pandemic: What theNuclear Medicine
Departments Should Know. J. Nucl. Med. Technol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312852
42. Pawar T, Pokharkar A, Gori J et al. The Technique and
Justification for Minimally Invasive Surgery inCOVID-19 Pandemic:
Laparoscopic Anterior Resection for Near Obstructed Rectal
Carcinoma. J.Laparoendosc. Adv. Surg. Tech. A 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315244
43. Casale TB, Wang J, Nowak-Wegrzyn A. Acute At Home Management
of Anaphylaxis During TheCovid-19 Pandemic. J Allergy Clin Immunol
Pract 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315792
44. Perini GF, Fischer T, Gaiolla RD et al. How to manage
lymphoid malignancies during novel 2019coronavirus (CoVid-19)
outbreak: a Brazilian task force recommendation. Hematol Transfus
Cell Ther2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32313873
45. Mathelin C, Nisand I. [Breast cancer management during the
COVID 19 pandemic: the CNGOF takesaction]. Gynecol Obstet Fertil
Senol 2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315805
-
46. Lim LW, Yip LW, Tay HW et al. Sustainable practice of
ophthalmology during COVID-19: challengesand solutions. Graefes
Arch Clin Exp Ophthalmol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314034
47. Marano L, Marrelli D, Roviello F. Cancer care under the
outbreak of COVID-19: A perspective fromItalian tertiary referral
center for surgical oncology. Eur. J. Surg. Oncol.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312591
48. Leboulanger N, Sagardoy T, Akkari M et al. COVID-19 and ENT
Pediatric otolaryngology during theCOVID-19 pandemic. Guidelines of
the French Association of Pediatric Otorhinolaryngology (AFOP)and
French Society of Otorhinolaryngology (SFORL). Eur. Ann.
Otorhinolaryngol. Head Neck Dis.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312676
49. Chevance A, Gourion D, Hoertel N et al. [Ensuring mental
health care during the SARS-CoV-2epidemic in France: A narrative
review]. Encephale 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312567
50. Wollina U. Challenges of Covid-19 Pandemic for Dermatology.
Dermatol Ther
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314460
51. Amerio P, Prignano F, Giuliani F, Gualdi G. COVID-19 and
psoriasis : should we fear for patients treatedwith biologics?
Dermatol Ther 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314483
52. DeFilippis EM, Farr MA, Givertz MM. Challenges in Heart
Transplantation in the Era of COVID-19.Circulation 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32314596
53. Ma S, Yuan Z, Peng Y et al. Experience and suggestion of
medical practices for burns during theoutbreak of COVID-19. Burns
2020. http://www.ncbi.nlm.nih.gov/pubmed/?term=32312568
54. Ellis R, Hay-David AGC, Brennan PA. Operating during the
COVID-19 pandemic: How to reducemedical error. Br. J. Oral
Maxillofac. Surg. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312584
55. Ahmed MZ, Ahmed O, Aibao Z et al. Epidemic of COVID-19 in
China and associated PsychologicalProblems. Asian J Psychiatr 2020;
51:102092. http://www.ncbi.nlm.nih.gov/pubmed/?term=32315963
56. Zhang J, Shuai L, Yu H et al. Acute stress, behavioural
symptoms and mood states among school-age children with
attention-deficit/hyperactive disorder during the COVID-19
outbreak. Asian JPsychiatr 2020; 51:102077.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315967
57. Diaz A, Sarac BA, Schoenbrunner AR et al. Elective surgery
in the time of COVID-19. Am. J. Surg.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312477
58. Jean WC, Ironside NT, Sack KD et al. The impact of COVID-19
on neurosurgeons and the strategy fortriaging non-emergent
operations: a global neurosurgery study. Acta Neurochir. (Wien.)
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32314059
59. Heffernan DS, Evans HL, Huston JM et al. Surgical Infection
Society Guidance for Operative and Peri-Operative Care of Adult
Patients Infected by the Severe Acute Respiratory Syndrome
Coronavirus-2(SARS-CoV-2). Surg Infect (Larchmt) 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32310715
60. Fallon A, Dukelow T, Kennelly SP, O'Neill D. COVID-19 in
Nursing Homes. QJM
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311049
61. Rajabally YA, Goedee HS, Attarian S, Hartung HP. Management
challenges for chronic dysimmuneneuropathies during the COVID-19
pandemic. Muscle Nerve
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311114
62. Song JC, Wang G, Zhang W et al. Chinese expert consensus on
diagnosis and treatment ofcoagulation dysfunction in COVID-19. Mil
Med Res 2020; 7:19.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307014
63. Practitioners specialized in oral health and coronavirus
disease 2019: Professional guidelines fromthe French society of
stomatology, maxillofacial surgery and oral surgery, to form a
common frontagainst the infectious risk. J Stomatol Oral Maxillofac
Surg 2020;
121:155-158.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307085
64. Crossley J, Clark C, Brody F, Maxwell JH. Surgical
Considerations for an Awake Tracheotomy Duringthe COVID-19
Pandemic. J. Laparoendosc. Adv. Surg. Tech. A
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311303
65. Nohuz E, Dubernard G, Lamblin G et al. [Gynecological
surgery during the COVID-19 Pandemic: takehome messages]. Gynecol
Obstet Fertil Senol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32311508
66. Campi R, Amparore D, Capitanio U et al. Assessing the Burden
of Nondeferrable Major Uro-oncologicSurgery to Guide Prioritisation
Strategies During the COVID-19 Pandemic: Insights from ThreeItalian
High-volume Referral Centres. Eur. Urol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307215
67. Tursen U, Tursen B, Lotti T. Coronavirus-Days in
Dermatology. Dermatol Ther
2020:e13438.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307810
68. Kamate SK, Sharma S, Thakar S et al. Assessing Knowledge,
Attitudes and Practices of dentalpractitioners regarding the
COVID-19 pandemic: A multinational study. Dent Med Probl 2020;
57:11-17. http://www.ncbi.nlm.nih.gov/pubmed/?term=32307930
69. Yang M, Dong H, Lu Z. Role of anaesthesiologists during the
COVID-19 outbreak in China. Br JAnaesth 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32307116
70. Samsami M, Zebarjadi Bagherpour J, Nematihonar B, Tahmasbi
H. COVID-19 Pneumonia inAsymptomatic Trauma Patients; Report of 8
Cases. Arch Acad Emerg Med 2020;
8:e46.http://www.ncbi.nlm.nih.gov/pubmed/?term=32309810
71. Michaud K, Wipfler K, Shaw Y et al. Experiences of Patients
with Rheumatic Diseases in the USDuring Early Days of the COVID-19
Pandemic. ACR Open Rheumatol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32311836
72. Arduino PG, Conrotto D, Broccoletti R. The outbreak of Novel
Coronavirus disease (COVID-19) causeda worrying delay in the
diagnosis of oral cancer in north-west Italy: the Turin
Metropolitan Areaexperience. Oral Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306459
73. Giannis D, Ziogas IA, Gianni P. Coagulation disorders in
coronavirus infected patients: COVID-19,SARS-CoV-1, MERS-CoV and
lessons from the past. J Clin Virol 2020;
127:104362.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305883
74. Freeman EE, McMahon DE, Fitzgerald ME et al. The AAD
COVID-19 Registry: CrowdsourcingDermatology in the Age of COVID-19.
J Am Acad Dermatol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305438
-
75. Krajewska J, Krajewski W, Zub K, Zatonski T. COVID-19 in
otolaryngologist practice: a review ofcurrent knowledge. Eur Arch
Otorhinolaryngol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306118
76. Mugheddu C, Dell'Antonia M, Sanna S et al. Successful
Guselkumab treatment in a psoriatic patientaffected with Cornelia
de Lange Syndrome, and prosecution during the COVID-19
pandemic.Dermatol Ther 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306513
77. Al Saleh AS, Sher T, Gertz MA. Multiple Myeloma in the Time
of COVID-19. Acta Haematol.
2020:1-7.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305989
Management1. Nikhat S, Fazil M. Overview of Covid-19; its
prevention and management in the light of Unani
medicine. Sci Total Environ 2020; 728:138859.
http://www.ncbi.nlm.nih.gov/pubmed/?term=323341632. Gupta S,
Federman DG. Hospital preparedness for COVID-19 pandemic:
Experience from department
of medicine at Veterans Affairs Connecticut Healthcare System.
Postgrad. Med.
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331509
3. Radovanovic D, Rizzi M, Pini S et al. Helmet CPAP to Treat
Acute Hypoxemic Respiratory Failure inPatients with COVID-19: A
Management Strategy Proposal. J Clin Med 2020;
9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32331217
4. Korsos A, Kupcsulik S, Lovas A et al. [Diagnostic steps and
estimation of disease prognosis in COVID-19-infected patients].
Orv. Hetil. 2020; 161:667-671.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324359
5. Wennmann DO, Dlugos CP, Hofschroer A et al. [Handling of
COVID-19 in the emergency department :Field report of the emergency
ward of the University Hospital Munster]. Med Klin
IntensivmedNotfmed 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32322988
6. Patel B. Comment on "Dermatology Residents and the Care of
COVID-19 Patients". J Am AcadDermatol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330631
7. Sharma KA, Kumari R, Kachhawa G et al. Management of the
first patient with confirmed COVID-19 inpregnancy in India: From
guidelines to frontlines. Int J Gynaecol Obstet
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32324897
8. Xu G, Yang Y, Du Y et al. Clinical Pathway for Early
Diagnosis of COVID-19: Updates from Experienceto Evidence-Based
Practice. Clin. Rev. Allergy Immunol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328954
9. Perricone C, Triggianese P, Bartoloni E et al. The anti-viral
facet of anti-rheumatic drugs: Lessons fromCOVID-19. J Autoimmun
2020:102468. http://www.ncbi.nlm.nih.gov/pubmed/?term=32317220
10. Choudhury R, Barrett CD, Moore HB et al. Salvage use of
tissue plasminogen activator (tPA) in thesetting of acute
respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a
Markovdecision analysis. World J Emerg Surg 2020; 15:29.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312290
11. Poonia SK, Rajasekaran K. Information Overload: A Method to
Share Updates among Frontline Staffduring the COVID-19 Pandemic.
Otolaryngol Head Neck Surg
2020:194599820922988.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315261
12. Song Y, Wang W, Zhang L et al. Optimization of the
intravenous infusion workflow in the isolationward for patients
with coronavirus disease 2019. Int J Nurs Sci
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32313713
13. Yao W, Wang T, Jiang B et al. Emergency tracheal intubation
in 202 patients with COVID-19 in Wuhan,China: lessons learnt and
international expert recommendations. Br J Anaesth
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312571
14. Lyons C. Fibreoptic tracheal intubation in COVID-19: not so
fast. Br J Anaesth
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32312573
15. Singer BD, Jain M, Budinger GRS, Wunderink RG. A Call for
Rational Intensive Care in the Era ofCOVID-19. Am. J. Respir. Cell
Mol. Biol. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315548
16. Sonis JD, Black L, Baugh J et al. Leveraging existing
quality improvement communication strategiesduring the COVID-19
crisis: Creation of an Emergency Department COVID-19 Case
Conference. AmJ Emerg Med 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32312576
17. Ma K, Chen T, Han MF et al. [Clinical consideration and
management of coronavirus disease 2019].Zhonghua Gan Zang Bing Za
Zhi 2020; 28:222-228.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306656
18. Litton E, Bucci T, Chavan S et al. Surge capacity of
intensive care units in case of acute increase indemand caused by
COVID-19 in Australia. Med. J. Aust. 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32306408
19. Lee SH, Son H, Peck KR. Can post-exposure prophylaxis for
COVID-19 be considered as one ofoutbreak response strategies in
long-term care hospitals? Int J Antimicrob Agents
2020:105988.http://www.ncbi.nlm.nih.gov/pubmed/?term=32305587
20. Baugh JJ, Sonis JD, Wittbold KA et al. Keeping pace: An ED
communications strategy for COVID-19.Am J Emerg Med 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305156
Meta-analyses - systematic reviews1. Castagnoli R, Votto M,
Licari A et al. Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2)
Infection in Children and Adolescents: A Systematic Review. JAMA
Pediatr 2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32320004
2. Huang I, Lim MA, Pranata R. Diabetes mellitus is associated
with increased mortality and severity ofdisease in COVID-19
pneumonia - A systematic review, meta-analysis, and
meta-regression.Diabetes Metab Syndr 2020; 14:395-403.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32334395
3. Huang X, Wei F, Yang Z et al. Lactose Dehydrogenase in
Patients with Severe COVID-19: A Meta-Analysis of Retrospective
Study. Prehosp. Disaster Med.
2020:1-9.http://www.ncbi.nlm.nih.gov/pubmed/?term=32326988
-
4. Loffredo L, Pacella F, Pacella E et al. Conjunctivitis and
COVID-19: a meta-analysis. J Med Virol
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32330304
5. Hu Y, Sun J, Dai Z et al. Prevalence and severity of corona
virus disease 2019 (COVID-19): Asystematic review and
meta-analysis. J Clin Virol 2020;
127:104371.http://www.ncbi.nlm.nih.gov/pubmed/?term=32315817
6. Chang TH, Wu JL, Chang LY. Clinical characteristics and
diagnostic challenges of pediatric COVID-19: A systematic review
and meta-analysis. J Formos Med Assoc
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32307322
7. Li JW, Han TW, Woodward M et al. The impact of 2019 novel
coronavirus on heart injury: A systemicreview and Meta-analysis.
Prog Cardiovasc Dis 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32305557
Mortality1. Wang L, Li J, Guo S et al. Real-time estimation and
prediction of mortality caused by COVID-19 with
patient information based algorithm. Sci Total Environ 2020;
727:138394.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334207
2. Farkas CB, Petretei D, Babinszky G et al. [What to do about
the deceased in suspected, probable andconfirmed COVID-19 cases].
Orv. Hetil. 2020; 161:713-722.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32324985
3. Parikh A, Kumar AA, Jahangir E. Cardio-oncology Care in the
Time of COVID-19 and the Role ofTelehealth. JACC CardioOncol 2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32328590
4. Ferdinand KC, Nasser SA. African American COVID-19 Mortality:
A Sentinel Event. J Am Coll Cardiol2020.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32330545
5. Ge Y, Sun S. Estimation of Coronavirus Disease Case-Fatality
Risk in Real Time. Emerg Infect Dis2020; 26.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32315282
6. Shojaee S, Pourhoseingholi MA, Ashtari S et al. Predicting
the mortality due to Covid-19 by the nextmonth for Italy, Iran and
South Korea; a simulation study. Gastroenterol Hepatol Bed Bench
2020;13:177-179.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32308940
On-line – IT – Apps1. Podpora M, Gardecki A, Beniak R et
al. Human Interaction Smart Subsystem-Extending Speech-Based
Human-Robot Interaction Systems with an Implementation of
External Smart Sensors. Sensors(Basel) 2020; 20.
http://www.ncbi.nlm.nih.gov/pubmed/?term=32331291
2. Wang L, Li J, Guo S et al. Real-time estimation and
prediction of mortality caused by COVID-19 withpatient information
based algorithm. Sci Total Environ 2020;
727:138394.http://www.ncbi.nlm.nih.gov/pubmed/?term=32334207
3. Wissel BD, Van Camp PJ, Kouril M et al. An Interactive Online
Dashboard for Tracking COVID-19 inU.S. Counties, Cities, and States
in Real Time. J Am Med Inform Assoc
2020.http://www.ncbi.nlm.nih.gov/pubmed/?term=32333753